Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex Cord-Stromal Tumors of the Ovary

NCT01042522 is registered in ClinicalTrials.gov with GOG Foundation as lead sponsor.

NCT NCT01042522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01042522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex Cord-Stromal Tumors of the Ovary
Lead sponsor
GOG Foundation
Phase
Phase 2
Overall status
Unknown status
Start date
February 8, 2010
Completion date
November 2, 2022
Enrollment
63 (actual)
Sites
219

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian granulosa cell tumor, ovarian gynandroblastoma, ovarian sertoli-leydig cell tumor, ovarian sex cord tumor with annular tubules, ovarian sex cord-stromal tumor, ovarian sex cord-stromal tumor, not otherwise specified, ovarian steroid cell tumor